Stai navigando con un browser obsoleto. per favore aggiorna il tuo browser per migliorare la tua esperienza e la tua sicurezza.

CDP Venture Capital
Maglie (LE) Life Science


Cartilago harnesses regenerative medicine to develop disease-modifying, chondroprotective technologies for combatting osteoarthritis and related pathologies. Cartilago directly target underlying disease pathology to offer not just symptomatic relief, but also to inhibit the typical natural progression of the disease. The technologies are being adapted to address additional indications, including for anti-aging solutions, wound care and anti-metastatic therapies in cancer.

The ecosystem supporting innovation in Italy